Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-014542

Chief Operating Officer sold 15,900 shares at $2.09 ($33,199)

From the SEC's structured data for this filing

Trades in this filing

Dagnon Terry · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-23 Sale : show line 1 in the form −15,900 $2.09 $33,199 1,127,857 D
Open-market sales · 15,900 sh · avg $2.09 · $33,199
Loading xslF345X03/doc4.xml…